Publication: Peritoneal administration of a subunit vaccine encapsulated in a nanodelivery system not only augments systemic responses against sars-cov-2 but also stimulates responses in the respiratory tract
Issued Date
2021-11-01
Resource Type
ISSN
19994915
Other identifier(s)
2-s2.0-85118705237
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Viruses. Vol.13, No.11 (2021)
Suggested Citation
Tuksin Jearanaiwitayakul, Suttikarn Apichirapokey, Runglawan Chawengkirttikul, Jitra Limthongkul, Mathurin Seesen, Phissinee Jakaew, Sakalin Trisiriwanich, Sompong Sapsutthipas, Panya Sunintaboon, Sukathida Ubol Peritoneal administration of a subunit vaccine encapsulated in a nanodelivery system not only augments systemic responses against sars-cov-2 but also stimulates responses in the respiratory tract. Viruses. Vol.13, No.11 (2021). doi:10.3390/v13112202 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77200
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Peritoneal administration of a subunit vaccine encapsulated in a nanodelivery system not only augments systemic responses against sars-cov-2 but also stimulates responses in the respiratory tract
Other Contributor(s)
Abstract
The COVID-19 pandemic has currently created an unprecedented threat to human society and global health. A rapid mass vaccination to create herd immunity against SARS-CoV-2 is a crucial measure to ease the spread of this disease. Here, we investigated the immunogenicity of a SARS-CoV-2 subunit vaccine candidate, a SARS-CoV-2 spike glycoprotein encapsulated in N,N,N-trimethyl chitosan particles or S-TMC NPs. Upon intraperitoneal immunization, S-TMC NP-immunized mice elicited a stronger systemic antibody response, with neutralizing capacity against SARS-CoV-2, than mice receiving the soluble form of S-glycoprotein. S-TMC NPs were able to stimulate the circulating IgG and IgA as found in SARS-CoV-2-infected patients. In addition, spike-specific T cell responses were drastically activated in S-TMC NP-immunized mice. Surprisingly, administration of S-TMC NPs via the intraperitoneal route also stimulated SARS-CoV-2-specific immune responses in the respiratory tract, which were demonstrated by the presence of high levels of SARS-CoV-2-specific IgG and IgA in the lung homogenates and bronchoalveolar lavages of the immunized mice. We found that peritoneal immunization with spike nanospheres stimulates both systemic and respiratory mucosal immunity.